Table 3 Comparing associations of heroin or illicitly manufactured fentanyl (IMF) use with clinical characteristics between NSDUH and NMUX in 2022. *Represents past year use. Stimulants were limited to cocaine and nonpharmaceutical amphetamines. Benzodiazepine use includes nonmedical use of prescription or nonpharmaceutical benzodiazepines
From: Comparison of heroin and fentanyl use in US nationally representative surveys
NSDUH Adjusted Odds Ratio (95% CI) | NMURx Adjusted Odds Ratio (95% CI) | |
|---|---|---|
Cigarette Use (Ref.: Every day) | ||
Some days | 0.94 (0.45, 1.96) | 1.19 (0.94, 1.51) |
Not at all / Blank | 0.19 (0.08, 0.44) | 0.46 (0.36, 0.58) |
Cannabis Use (Ref: None)* | 1 (0.53, 1.91) | 1.19 (0.93, 1.51) |
Heavy alcohol use (Ref: No) | 1.08 (0.45, 2.6) | 1.17 (0.8, 1.71) |
Stimulant use (Ref: None)* | 11.06 (6.22, 19.65) | 27.52 (21.14, 35.83) |
Benzodiazepine use (Ref: None)* | 6.17 (3.68, 10.36) | 4.1 (3.09, 5.44) |
Medication for OUD use (Ref: None)* | 22.06 (13.05, 37.3) | 9.43 (6.31, 14.07) |
Hospitalization in past year (Ref: None) | 1.02 (0.47, 2.19) | 1.89 (1.43, 2.49) |